Ticker Details
iRhythm Technologies, Inc. iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities.
IPO Date:	October 20, 2016
Sector:	Healthcare
Industry:	Medical Instruments and Equipment
Market Cap:	$3.82B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$2.33 | 2.23%
Avg Daily Range (30 D):	$1.97 | 1.63%
Avg Daily Range (90 D):	$2.80 | 1.85%

Institutional Daily Volume
Avg Daily Volume:	.35M
Avg Daily Volume (30 D):	.47M
Avg Daily Volume (90 D):	.5M

Trade Size
Avg Trade Size (Sh.):	52
Avg Trade Size (Sh.) (30 D):	48
Avg Trade Size (Sh.) (90 D):	46

Institutional Trades
Total Institutional Trades:	4,794
Avg Institutional Trade:	$3.23M
Avg Institutional Trade (30 D):	$4.49M
Avg Institutional Trade (90 D):	$5.36M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.21M
Avg Closing Trade (30 D):	$8.4M
Avg Closing Trade (90 D):	$8.47M
Avg Closing Volume:	38.06K

News

Jan 14, 2026 @ 5:43 PM iRhythm Tech's Stock Selloff Went Too Far After Pr... Source: Vandana Singh

Nov 11, 2025 @ 10:05 PM NEXGEL (NXGL) Q3 2025 Earnings Call Transcript Source: Motley Fool Transcribing

Oct 30, 2025 @ 5:00 PM Global Cardiac Monitoring Devices Market to Cross ... Source: Delveinsight

Aug 29, 2025 @ 11:00 AM AMALFI Randomized Clinical Trial Results Demonstra... Source: Oxford University

Jun 18, 2025 @ 12:48 AM Robbins LLP Informs iRhythm Technologies, Inc. (IR... Source: N/A

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.39	$.18	$-1.39
Diluted EPS	$-1.39	$.18	$-1.39
Revenue	$747.14M	$208.89M	$747.14M
Gross Profit	$527.25M	$148.06M	$527.25M
Net Income / Loss	$-44.55M	$5.58M	$-44.55M
Operating Income / Loss	$-57.41M	$2.29M	$-57.41M
Cost of Revenue	$219.89M	$60.84M	$219.89M
Net Cash Flow	$-183.59M	$-19.63M	$-183.59M
PE Ratio